Log in

Aeglea Bio Therapeutics Price Target & Analyst Ratings (NASDAQ:AGLE)

$7.77
+0.17 (+2.24 %)
(As of 10/17/2019 09:20 AM ET)
Today's Range
$7.58
Now: $7.77
$7.84
50-Day Range
$7.21
MA: $7.91
$8.79
52-Week Range
$5.99
Now: $7.77
$10.28
Volume14,173 shs
Average Volume57,033 shs
Market Capitalization$224.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08

Analyst Ratings

Aeglea Bio Therapeutics (NASDAQ:AGLE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Aeglea Bio Therapeutics in the last 12 months. Their average twelve-month price target is $17.00, suggesting that the stock has a possible upside of 118.79%. The high price target for AGLE is $20.00 and the low price target for AGLE is $14.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.672.75
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.00$17.00$17.00$24.00
Price Target Upside: 118.79% upside172.44% upside172.44% upside196.66% upside

Aeglea Bio Therapeutics (NASDAQ:AGLE) Consensus Price Target History

Aeglea Bio Therapeutics (NASDAQ:AGLE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/3/2019HC WainwrightReiterated RatingBuy$20.00Low
3/21/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$14.00Medium
9/4/2018Wells Fargo & CoDowngradeOutperform ➝ Market PerformHigh
6/14/2018BMO Capital MarketsInitiated CoverageOutperform$21.00High
4/24/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$37.00High
4/13/2018Needham & Company LLCBoost Price TargetBuy$20.00High
(Data available from 10/17/2017 forward)
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel